logo
  1. Home
  2. Stocks
  3. Lincoln Pharmaceuticals

Lincoln Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | NSE: LINCOLN | BSE: 531633

₹528.70 image1.95 (0.37 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 525.95

High (₹) 540.25

Low (₹) 524.45

Prev. Close (₹) 526.75

Volume 13,520

VWAP (₹) 528.99

ROCE (%) 20.34

Industry P/E 43.95

TTM P/E 11.85

P/B Ratio 1.78

Market Cap (₹) Cr.1,055.47

Dividend Yield (%)0.34

EPS (₹) 46.58

ROE15.74%

Sales Growth (%) 13.76

Profit Growth (%)27.99

Day Range

540.25540.25

L
H

52 Week Range

498.00975.00

L
H

Historical Returns

Returns (6M)

-30.16 %

Returns (1Y)

-8.3 %

Returns (3Y)

70.66 %

Returns (5Y)

363.77 %

Returns (6M)

-30.16 %

Returns (1Y)

-8.3 %

Returns (3Y)

70.66 %

Returns (5Y)

363.77 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (27.97%) TTM EPS Growth
  • Company with no debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 27.97% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 16.02

MFI 4.44

ATR 40.78

Commodity Channel Index -97.91

ROC125 -25.51

ROC21 -25.43

Williams %R -97.91

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current550.46580.53598.01532.98502.91485.43455.36
Week Ago580.21593.58605.26568.53555.16543.48530.11
Month Ago695.56715.08741.26669.38649.86623.68604.16

EMA & SMA
info_icon

528.70

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 558.89

9 Day 563.33

10 Day 560.62

12 Day 597.91

14 Day 608.89

20 Day 639.25

26 Day 651.43

50 Day 726.45

100 Day 714.50

200 Day 684.44

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
06 Jun, 2024Munjal Mahendrabhai PatelAcquisition₹541.5013,500BSE
03 Jun, 2024Munjal Mahendrabhai PatelAcquisition₹568.2520,000BSE
03 Jun, 2024Munjal Mahendrabhai PatelAcquisition₹564.6015,000BSE
28 Feb, 2024Renukaben Maheshbhai PatelDisposal₹747.291,500BSE
28 Feb, 2024Patel Nishitkumar MaheshbhaiDisposal₹751.141,000BSE
28 Feb, 2024Patel Nishitkumar MaheshbhaiDisposal₹733.501,000BSE
24 Feb, 2024Renukaben Maheshbhai PatelDisposal₹713.2162,500BSE
24 Feb, 2024Patel Nishitkumar MaheshbhaiDisposal₹727.2326,500BSE
23 Feb, 2024Anand Arvindbhai PatelAcquisition₹690.4830,000BSE
22 Feb, 2024Renukaben Maheshbhai PatelDisposal₹710.6211,353BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
16 May, 2024Rs.1.8000 per share(18%)Final Dividend13 Sept, 202401 Jan, 1970
25 May, 2023Rs.1.5000 per share(15%)Dividend15 Sept, 202301 Jan, 1970
19 May, 2022Rs.1.5000 per share(15%)Dividend15 Sept, 202201 Jan, 1970

Announcements

DateSourceDetail
07 Mar, 2025NSE IndiaThe Exchange had sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
04 Mar, 2025NSE IndiaThe Exchange has sought clarification from Lincoln Pharmaceuticals Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
14 Feb, 2025NSE IndiaLincoln Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
13 Feb, 2025NSE IndiaIntegrated Filing (Financial) for the Quarter and Nine Months ended 31st December, 2024
13 Feb, 2025BSE IndiaIntegrated Filing (Financials) for the Quarter and Nine Months ended 31st December, 2024.
13 Feb, 2025BSE IndiaUN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED ON 31.12.2024\r\n
13 Feb, 2025NSE IndiaLincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
13 Feb, 2025BSE IndiaUN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2024
05 Feb, 2025NSE IndiaLINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
05 Feb, 2025BSE IndiaLINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December, 2024 And Other Business if any.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--06 Feb, 202513 Feb, 2025
Quarterly Results--06 Nov, 202414 Nov, 2024
Quarterly Results--31 Jul, 202408 Aug, 2024
Audited Results & Final Dividend--10 May, 202416 May, 2024
Quarterly Results--30 Jan, 202408 Feb, 2024
Quarterly Results--25 Oct, 202302 Nov, 2023
Quarterly Results--31 Jul, 202310 Aug, 2023
Audited Results & Dividend--16 May, 202325 May, 2023
Quarterly Results--01 Feb, 202309 Feb, 2023
Quarterly Results--31 Oct, 202210 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Lincoln Pharmaceuticals

Lincoln Pharmaceuticals is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 580.55 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1995

Managing Director

Mr. Mahendra G Patel

NSE Symbol

LINCOLN

Lincoln Pharmaceuticals Management

NameDesignation
Mr. Kishor M ShahNon Executive Chairman
Mr. Mahendra G PatelManaging Director
Mr. Hashmukh I PatelWhole Time Director
Mr. Munjal M PatelWhole Time Director
Mr. Ashish R PatelWhole Time Director
Mr. Rajnikant G PatelNon Executive Director
Mr. Nareshkumar SutharIndependent Director
Mr. Saurin J ParikhIndependent Director
Ms. Seema MehtaIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)		₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)		₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)		₹1,093.000 - ₹1,420.200

FAQs on Lincoln Pharmaceuticals

What is the share price of Lincoln Pharmaceuticals?

The share price of Lincoln Pharmaceuticals on 13 Mar, 2025 is ₹ 528.70.

What is 52W high and 52W low share price of Lincoln Pharmaceuticals?

The highest and lowest 52W share prices of Lincoln Pharmaceuticals are ₹ 975.000 and ₹ 498.000

What is the market cap of Lincoln Pharmaceuticals?

The market capitalization of Lincoln Pharmaceuticals as of 13 Mar, 2025 is ₹ 1,055.47 Crores

What is the P/E ratio of Lincoln Pharmaceuticals?

The current P/E ratio of Lincoln Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Lincoln Pharmaceuticals?

The PB ratio of Lincoln Pharmaceuticals as of 13 Mar, 2025 is 1.78

Top Gainers

PASUSPG

Pasupati Spinning & Weaving Mills

₹41.02image

₹34.29 (0.20%)

OONE

ObjectOne Information Systems

₹8.84image

₹7.37 (0.20%)

JAINCO

Jainco Projects (India)

₹6.97image

₹5.81 (0.20%)

HITECHCORP

Hitech Corporation

₹194.70image

₹162.25 (0.20%)

Top Losers

MEHAI

Mehai Technology

₹13.75image

₹135.15 (-0.90%)

TRESCON

Trescon

₹9.60image

₹12.00 (-0.20%)

SAGL

Shalimar Agencies

₹9.80image

₹93.55 (-0.90%)

SHANGAR

Shangar Decor

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited